bf/NASDAQ:ANIK_icon.jpeg

COM:ANIKA

Anika Therapeutics

  • Stock

Last Close

17.43

22/11 21:00

Market Cap

389.26M

Beta: -

Volume Today

61.03K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
20.57M
-
38.32M
86.25%
30.76M
19.73%
32.55M
5.82%
31.82M
2.25%
18.72M
41.16%
27.19M
45.25%
-23.98M
188.19%
4.13M
117.24%
-14.86M
459.43%
-82.67M
456.34%
depreciation and amortization
4.77M
-
4.71M
1.40%
3.77M
19.78%
3.73M
1.09%
4.29M
14.89%
5.91M
37.76%
5.99M
1.37%
13.46M
124.74%
14.32M
6.34%
14.49M
1.19%
14.23M
1.75%
deferred income tax
1.35M
-
-8.81M
753.25%
-1.59M
81.91%
-712K
55.33%
-1.20M
68.26%
-1.82M
51.67%
794K
143.70%
-3.54M
546.22%
-1.77M
50.16%
-5.27M
198.41%
-6.33M
20.06%
stock based compensation
1.27M
-
1.61M
26.76%
2.23M
38.42%
3.39M
52.45%
5.81M
71.20%
11.05M
90.22%
6.09M
44.89%
5.39M
11.52%
11.09M
105.81%
14.31M
29.14%
15.24M
6.48%
change in working capital
-2.92M
-
3.78M
229.37%
2.96M
21.81%
-15.87M
636.92%
-2.36M
85.14%
-3.20M
35.77%
-6.64M
107.59%
-13.46M
102.59%
-14.72M
9.36%
-11.82M
19.68%
-12.12M
2.55%
accounts receivables
2.41M
-
897.56K
62.78%
-5.00M
656.62%
-6.20M
24.12%
2.67M
143.12%
2.91M
8.98%
-1.84M
163.11%
5.86M
418.38%
-6.22M
206.17%
-5.63M
9.43%
-1.30M
76.82%
inventory
-2.82M
-
-1.97M
30.06%
-2.94M
48.85%
-1.74M
40.86%
-6.52M
275.20%
-7.58M
16.19%
-5.58M
26.29%
-14.18M
153.84%
-6.62M
53.31%
-6.87M
3.84%
-11.40M
65.81%
accounts payables
622.93K
-
-749.60K
220.34%
5.63M
850.40%
-5.06M
189.94%
3.89M
176.89%
-1.67M
142.96%
767K
145.90%
822K
7.17%
-1.10M
233.82%
1.97M
278.64%
-11K
100.56%
other working capital
-3.13M
-
5.61M
278.96%
5.26M
6.07%
-2.87M
154.47%
-2.40M
16.32%
3.13M
230.58%
14K
99.55%
-5.96M
42,657.14%
-783K
86.86%
-1.28M
63.86%
589K
145.91%
other non cash items
122.32K
-
377.75K
208.83%
945K
150.16%
706K
25.29%
2.45M
247.59%
4.26M
73.47%
3.58M
15.83%
35.20M
882.36%
-4.66M
113.23%
7.56M
262.34%
69.85M
824.34%
net cash provided by operating activities
25.17M
-
39.98M
58.86%
39.06M
2.29%
23.80M
39.07%
40.81M
71.47%
34.92M
14.44%
37.01M
5.98%
13.06M
64.69%
8.40M
35.73%
4.41M
47.49%
-1.79M
140.55%
investments in property plant and equipment
-440.89K
-
-1.55M
252.22%
-9.22M
494.04%
-14.01M
51.91%
-8.98M
35.92%
-4.66M
48.15%
-2.83M
39.28%
-1.63M
42.41%
-5.14M
215.91%
-7.49M
45.56%
-5.43M
27.50%
acquisitions net
-42.52M
-
-94.60M
122.50%
-476K
99.50%
purchases of investments
-26.75M
-
-45.25M
69.16%
-39.25M
13.26%
-45M
14.65%
-91.60M
103.56%
-103.85M
13.37%
-20.04M
80.71%
-2.02M
89.89%
sales maturities of investments
20M
-
24.25M
21.25%
46.50M
91.75%
41.50M
10.75%
46M
10.84%
146.37M
218.19%
45M
69.26%
2.50M
94.44%
other investing activites
187.74K
-
42.52M
-
2.02M
-
net cash used for investing activites
-253.16K
-
-8.30M
3,179.78%
-30.23M
264.04%
-6.76M
77.63%
-12.48M
84.53%
-50.26M
302.70%
39.69M
178.98%
-71.26M
279.55%
-3.12M
95.62%
-7.49M
140.09%
-5.43M
27.50%
debt repayment
-9.60M
-
-50.56M
-
-201K
99.60%
-284K
41.29%
common stock issued
22.15M
-
1.52M
93.12%
1.13M
25.98%
681K
39.63%
828K
21.59%
common stock repurchased
-25M
-
-30M
-
-30M
0%
-262K
99.13%
-486K
85.50%
-934K
92.18%
-5M
435.33%
dividends paid
-1.26M
-
-642K
49.13%
-253K
60.59%
other financing activites
3.91M
-
5.33M
36.34%
1.92M
63.97%
1.65M
13.90%
314K
81.02%
1.10M
249.04%
-293K
126.73%
46.78M
16,067.24%
-6.58M
114.06%
-4.06M
38.25%
-2.15M
47.02%
net cash used provided by financing activities
-5.69M
-
5.33M
193.72%
1.92M
63.97%
-23.35M
1,315.30%
314K
101.34%
-28.90M
9,305.10%
-8.14M
71.83%
-3.77M
53.65%
-6.78M
79.62%
-4.85M
28.43%
-6.32M
30.34%
effect of forex changes on cash
43.07K
-
-184.62K
528.69%
-208K
12.66%
-138K
33.65%
349K
352.90%
29K
91.69%
-133K
558.62%
327K
345.86%
69K
78.90%
-130K
288.41%
79K
160.77%
net change in cash
19.27M
-
36.82M
91.13%
10.55M
71.35%
-6.45M
161.09%
29.00M
549.81%
-44.21M
252.49%
68.42M
254.75%
-61.65M
190.10%
-1.43M
97.68%
-8.06M
463.17%
-13.46M
67.02%
cash at beginning of period
44.07M
-
63.33M
43.72%
100.16M
58.14%
110.71M
10.53%
104.26M
5.82%
133.26M
27.81%
89.04M
33.18%
157.46M
76.84%
95.82M
39.15%
94.39M
1.49%
86.33M
8.54%
cash at end of period
63.33M
-
100.16M
58.14%
110.71M
10.53%
104.26M
5.82%
133.26M
27.81%
89.04M
33.18%
157.46M
76.84%
95.82M
39.15%
94.39M
1.49%
86.33M
8.54%
72.87M
15.59%
operating cash flow
25.17M
-
39.98M
58.86%
39.06M
2.29%
23.80M
39.07%
40.81M
71.47%
34.92M
14.44%
37.01M
5.98%
13.06M
64.69%
8.40M
35.73%
4.41M
47.49%
-1.79M
140.55%
capital expenditure
-440.89K
-
-1.55M
252.22%
-9.22M
494.04%
-14.01M
51.91%
-8.98M
35.92%
-4.66M
48.15%
-2.83M
39.28%
-1.63M
42.41%
-5.14M
215.91%
-7.49M
45.56%
-5.43M
27.50%
free cash flow
24.72M
-
38.43M
55.42%
29.84M
22.35%
9.79M
67.20%
31.83M
225.25%
30.26M
4.93%
34.18M
12.94%
11.44M
66.54%
3.25M
71.55%
-3.08M
194.56%
-7.21M
134.48%

All numbers in (except ratios and percentages)